Total : 5 View more »
Affymetrix and Beckman Coulter have entered into an agreement to offer researchers, co-developed products in microarrays and automated liquid handlers.
http://www.pharmaasia.com/article-7975-affymetrixandbeckmancoulterteamup-asia.html
Affymetrix, Inc. (Nasdaq:AFFX) announced today that the Institute for Pharmacogenomics and Individualized Therapy (IPIT) at the University of North Carolina in Chapel Hill is using the company’s DMET™ Plus biomarker panel to expand the Pharmacogeneti
http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=9409
NEW YORK, November 4 (newratings.com) - Analysts at Deutsche Bank Securities upgrade Affymetrix (ticker: AFFX) from "sell" to "hold." The target price is set to $6.5. [more]
http://www.newratings.com/en/main/company_headline.m?id=1985795
Affymetrix Inc., which makes genetic analysis technology, on Wednesday reported a narrower third-quarter loss, but the results missed Wall Street expectations, sending shares plunging in after-hours trading. The company posted a loss of $8.8 million, or 13...
Total : 51 View more »
Nov 23, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Affymetrix (NASDAQ:AFFX) on October 22, 2009 at $7.50.
Since then, Affymetrix has returned 36.4% as of today's recent price of $4.77. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq profit securities trial
Companies: Affymetrix, Inc. (AFFX)
Nov 17, 2009 (SmarTrend(R) Research Reports via COMTEX) --
SmarTrend, the proprietary pattern recognition system, has made available a free sample copy of our premium research report on (NASDAQ:AFFX) at http://www.mysmartrend.com/research/
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Affymetrix (NASDAQ:AFFX) on October 22, 2009 at $7.50. Since then, Affymetrix has returned 31.8% as of today's recent price of $5.12.
Want access to these reports and real time alerts? Go to www.tradethetrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq research securities trial
Companies: Affymetrix, Inc. (AFFX)
Nov 10, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Affymetrix (NASDAQ:AFFX) on October 22, 2009 at $7.50.
Since then, Affymetrix has returned 26.8% as of today's recent price of $5.49. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq profit securities trial
Companies: Affymetrix, Inc. (AFFX)
Nov 04, 2009 (SmarTrend(R) Spotlight via COMTEX) --
Affymetrix (NASDAQ:AFFX) upgraded to Hold from Sell, $6.50 target, at Deutsche Bank. The stock closed yesterday at $5.26 on volume of 1,428,800 shares, above average daily volume of 1,172,853.
Affymetrix is currently below its 50-day moving average of $8.35 and below its 200-day moving average of $5.71.
SmarTrend is bearish on shares of AFFX and our subscribers received a Downtrend alert on October 22, 2009 at $7.50, which has returned 29.9% to date.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq securities
Companies: Affymetrix, Inc. (AFFX)
Total : 588 View more »
Affymetrix Inc was one of the pioneering companies in genetic microarray technology in the 1980s. It now manufactures products for genetic research including diagnostic tools and microarray systems for genome elucidation.
http://www.pharmaceutical-technology.com/projects/affymatrix/
These products continue to accelerate genetic research and enable scientists to develop diagnostics and tailor treatments for individual patients by identifying and measuring the genetic information associated with complex diseases. More >
In a recent survey of academic DNA microarray users, the management of data resulting from research was cited as the number one challenge. Are manufacturers addressing this going forward or will they let "freeware" serve the needs of this group?
http://www.dddmag.com/bioinformatics-and-DNA-microarrays.aspx
The FlashTag kit will label any RNA sample, including total RNA and miRNA, for hybridization to Affymetrix GeneChip miRNA arrays. FlashTag labeling is simple, accurate and highly sensitive. The entire procedure takes 45 minutes and there are no purification steps.
Total : 238 View more »
Affymetrix Incorporated, Santa Clara, CA : Reviews and maps - Yahoo! Local, 408.731.5000. Get Ratings, Reviews, Photos and more on Yahoo! Local.
http://local.yahoo.com/info-21586001-affymetrix-incorporated-santa-clara
Get the latest AFFX - Affymetrix Incorporated stock market performance data. TheStreet is the source for financial market news, trading stock, quotes, and personal finance advice.
ON AFFYMETRIX INCORPORATED: ICON GROUP INTERNATIONAL LTD. PUBLISHES VERTICAL ANALYSIS AND LABOR UTILIZATION BENCHMARKS . San Diego —-- Two of the most comprehensive vertical gap ...
http://www.icongrouponline.com/pr/Affymetrix_Incorporated_US/PR.html
Kevin M. King, President/Director/CEO . 3420 Central Expressway. Santa Clara, CA 95051 US Map it
http://origin.www.portfolio.com/resources/company-profiles/Affymetrix-Incorporated-3265/news
Tom Downey demonstrates how Partek® Genomics Suite Version 6.3 can perform interactive primary and secondary copy number analyses for the SNP Arrays 6.0.
http://www.affymetrix.com/userForum/event/Symposium_PartekGSV63.uf
MAGE_ML has been automatically derived from Microarray Gene Expression Object Model (MAGE-OM), which is developed and described using the Unified Modeling Language (UML) - a standard for describing object models (above paragraph adopted from the Microarray Gene Expression Data Group).
Added support for the GCOS 1.0 file security feature. The Exporter SDK will be able to read the data files managed by the GCOS 1.0 when the file security feature is enabled.
The MAGE-ML Exporter SDK Version 2.0 BETA is set of application programming interfaces (APIs) used to create MAGE-ML compliant documents for files generated by GCOS, Affymetrix GeneChip® Command Console and Expression Console™ software.